massarray lungfusion v1.0 panel Search Results


90
agena bioscience massarray lungfusion v1.0 panel
Summary of fusion detection results.
Massarray Lungfusion V1.0 Panel, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray lungfusion v1.0 panel/product/agena bioscience
Average 90 stars, based on 1 article reviews
massarray lungfusion v1.0 panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Summary of fusion detection results.

Journal: Scientific Reports

Article Title: Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

doi: 10.1038/srep42259

Figure Lengend Snippet: Summary of fusion detection results.

Article Snippet: Multiplex screening of the samples was performed using the MassARRAY LungFusion v1.0 Panel (Agena Bioscience, San Diego, CA, USA) followed by a LungFusion Assay by Agena (AbA) ALK, RET and ROS1 Variant Panels (Agena Bioscience, San Diego, CA, USA) for further characterization of fusion positive samples.

Techniques: Staining, Variant Assay

Technical basis and performance characteristics of each platform.

Journal: Scientific Reports

Article Title: Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

doi: 10.1038/srep42259

Figure Lengend Snippet: Technical basis and performance characteristics of each platform.

Article Snippet: Multiplex screening of the samples was performed using the MassARRAY LungFusion v1.0 Panel (Agena Bioscience, San Diego, CA, USA) followed by a LungFusion Assay by Agena (AbA) ALK, RET and ROS1 Variant Panels (Agena Bioscience, San Diego, CA, USA) for further characterization of fusion positive samples.

Techniques: Sequencing, Hybridization, Reverse Transcription, Next-Generation Sequencing, Expressing, Software